Therefore, we next analyzed CD99 surface protein expression on T cells from the CSF of MS patients (n = 24 females, 9 males) and of patients with non-neuroinflammatory diseases (NND patients; n = 11 females, 5 males). Here, CD99 is linked to myeloid sarcoma.